Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

COVID paused prevention efforts, which helped fuel the rise in new infections. Now federal funding cuts threaten to disrupt those efforts again.

According to the CDC, there has been a decline in animal infections and no reports of human cases since February.

Congress just passed a sweeping bill that includes changes to Medicaid expected to cut millions of people with low incomes ...

The fact that lenacapavir will soon be available to patients is a testament to the strength of America's biopharmaceutical ...

HIV Testing Atlanta took center stage on Thursday, June 26, as Streetz 94.5 and rolling out magazine joined forces with the ...

How will the Trump administration's cuts to HIV research impact the progress that's been made towards ending the epidemic in the U.S.?

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

Former CDC officials warn that proposed fiscal 2026 budget cuts would slash funding by 54%, threatening critical health ...

Widespread use of contemporary antiretroviral therapy globally has transformed HIV disease into a chronic illness associated with excess risk for disorders of the heart and circulatory system. Current ...

While Congress fails to stave off cuts to HIV care, community leaders in Mississippi and beyond race to limit the damage.

The lab's 25 or so full-time employees were put on administrative leave on March 27, forcing it to shut down operations.